TriSalus Life Sciences Inc. is a medical technology and drug delivery company focused on developing breakthrough diagnostic and therapeutic solutions for patients suffering from liver and pancreas tumors. By utilizing proprietary Pressure-Enabled Drug Delivery (PEDD) technology, the enterprise aims to overcome high intratumoral pressure barriers, thereby enhancing therapeutic delivery and improving clinical outcomes for complex oncological indications.